Entries by Andrew Glover

Upcoming events in 2013

Here are some of the events Fusion Antibodies will be attending in 2013 Happy New Year Everyone! Here are some of the events Fusion Antibodies will be attending in 2013: BioEurope Spring 2013 – http://www.ebdgroup.com/bes/ – March 11th – 13th 2013 – Barcelona Bio 2013 – http://convention.bio.org/ – April 22nd -25th 2013 – Chicago Anglonordic Biotech Conference – http://www.anglonordicbiotech.com/ – June […]

New service – bi-specific antibodies!

Fusion Antibodies are proud to offer a new and unique service of generation of antibodies which are hybrids of two of your Therapeutic monoclonals. With the recent press attention surrounding the first FDA approved bi-specific antibody; catumaxomab and the announcement of the Humanization of Fusion Therapeutics very own fsn1006 double-targeting antibody, there has never been a better time to […]

Meet fusion at ECC 2012

Fusion Antibodies will be attending this years European Cancer Cluster conference on November 11th in Hamburg, Germany. Update: Fusion Antibodies will now be presenting our recent announcement of the humanization of the double EGF targeting fsn1006 antibody at ECC 2012! Fusion Antibodies will be attending this years European Cancer Cluster conference on November 11th in Hamburg, Germany. If you would like to meet us […]

“One stop” antibody humanization

Fusion Antibodies have the knowledge and expertise to take your project from ANY stage and produce a fully humanized monoclonal antibody ready for cGMP scale up. Whether you have a murine monoclonal antibody, an antibody sequence, a recombinant protein or even an ascension number for an interesting target, Fusion Antibodies can work with you to develop a humanized […]

Upcoming conferences – HAH & Bioeurope 2012

Fusion Antibodies will be attending HAH 2012 and Bioeurope 2012. We look forward to seeing you there! Human Antibodies and Hybridomas Conference 2012 Dr Richard Buick will be speaking at this years Human Antibodies & Hybridomas conference in Orlando, Florida. The conference will include lectures, papers and posters surrounding key aspects of human antibody and hybridoma technology, applications and engineering. […]

Contract manufacturing summit 2012

Fusion Antibodies will be speaking at this years Contract Manufacturing Summit 2012. The conference takes place from 2nd-3rd October in London, UK at the Hilton Olympia Hotel. This years conference looks set to cover some great topics including; relationship development and management, business models and strategies for the CMO industry and the major challenges of contract manufacturing projects. […]

Challenge us to increase your yields!

Whatever stage your research project is at, whatever your current expression/purity levels are we want to improve them! Here at Fusion Antibodies we always want the best. We want higher protein expression levels, higher purity, more stability and lower expression and purification time-scales. Through many years of contract research Fusion Antibodies have developed the expertise to be the best […]

New blood test reduces diagnostic time for bovine tuberculosis

A new blood test developed by Enfer Scientific Ltd, Ireland in collaboration with Fusion Antibodies could see significantly faster and more accurate testing for TB in cattle. The ELISA based assay was developed using Fusion’s unique FET platform for expression of recombinant proteins in E.coli. Our platform provides a reliable, professional service for the expression of your gene […]

Antibody sequencing service – an Olympic offer

To enter into the spirit of the Olympic games we want to offer our Gold standard Antibody sequencing service with an additional 20% discount Here at Fusion Antibodies we are excited to have the London 2012 Olympics starting later this week. Watching the athletes from around the world competing, in a demonstration of human excellence […]

Bio 2012 – how was it for you?

A month has passed from the last BIO conference in Boston (www.bio.org) and the dust has settled to review. Fusion Antibodies has been attending this great event over the past 12 years and although the numbers have fallen from the 20,000+ attendee peaks in 2007/08 the networking opportunities and value this conference brings is at […]